Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial.

Publication ,  Journal Article
Pollock, MD; Stauffer, N; Lee, H-J; Chow, S-C; Satoru, I; Moats, L; Swan-Nesbit, S; Li, Y; Roberts, JK; Ellis, MJ; Diamantidis, CJ ...
Published in: Transplant Direct
April 2023

UNLABELLED: Kidney transplant (KT) recipients who are not actively engaged in their care and lack self-management skills have poor transplant outcomes, which are disproportionately observed among Black KT recipients. This pilot study aimed to determine whether the MyKidneyCoach app, an mHealth intervention that provides self-management monitoring and coaching, improved patient activation, engagement, and nutritional behaviors in a diverse KT population. METHODS: This was a randomized, age-stratified, parallel-group, attention-control, pilot study in post-KT patients. Participants were randomized into the attention-control with access to MyKidneyCoach for education and self-management (n = 9) or the intervention with additional tailored nurse coaching (n = 7). Feasibility, acceptability, and clinical outcomes were assessed. RESULTS: The acceptability of MyKidneyCoach by System Usability Scale was 67.5 (95% confidence interval [CI], 59.1-75.9). Completion rates based on actively using MyKidneyCoach were 81% (95% CI, 57%-93%) and study retention rate of 73%. Patient activation measure significantly increased overall by a mean of 11 points (95% CI, 3.2-18.8). Additionally, Black patients (n = 7) had higher nutrition self-efficacy scores of 80.5 (95% CI, 74.4-86.7) compared with 75.6 (95% CI, 71.1-80.1) in non-Black patients (n = 9) but lower patient activation measure scores of 69.3 (95% CI, 56.3-82.3) compared with 71.8 (95% CI, 62.5-81) in non-Black patients after 3 mo. CONCLUSIONS: MyKidneyCoach was easy to use and readily accepted with low attrition, and improvements were demonstrated in patient-reported outcomes. Both Black and non-Black participants using MyKidneyCoach showed improvement in self-management competencies; thus, this intervention may help reduce healthcare inequities in KT.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transplant Direct

DOI

ISSN

2373-8731

Publication Date

April 2023

Volume

9

Issue

4

Start / End Page

e1462

Location

United States

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pollock, M. D., Stauffer, N., Lee, H.-J., Chow, S.-C., Satoru, I., Moats, L., … Chambers, E. T. (2023). MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial. Transplant Direct, 9(4), e1462. https://doi.org/10.1097/TXD.0000000000001462
Pollock, McLean D., Nicolas Stauffer, Hui-Jie Lee, Shein-Chung Chow, Ito Satoru, Lynnette Moats, Sherri Swan-Nesbit, et al. “MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial.Transplant Direct 9, no. 4 (April 2023): e1462. https://doi.org/10.1097/TXD.0000000000001462.
Pollock MD, Stauffer N, Lee H-J, Chow S-C, Satoru I, Moats L, et al. MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial. Transplant Direct. 2023 Apr;9(4):e1462.
Pollock, McLean D., et al. “MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial.Transplant Direct, vol. 9, no. 4, Apr. 2023, p. e1462. Pubmed, doi:10.1097/TXD.0000000000001462.
Pollock MD, Stauffer N, Lee H-J, Chow S-C, Satoru I, Moats L, Swan-Nesbit S, Li Y, Roberts JK, Ellis MJ, Diamantidis CJ, Docherty SL, Chambers ET. MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot Trial. Transplant Direct. 2023 Apr;9(4):e1462.

Published In

Transplant Direct

DOI

ISSN

2373-8731

Publication Date

April 2023

Volume

9

Issue

4

Start / End Page

e1462

Location

United States

Related Subject Headings

  • 3204 Immunology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology